Trial Profile
Study of Febuxostat and Topiroxostat in Hypertensive Patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Jun 2021
Price :
$35
*
At a glance
- Drugs Febuxostat (Primary) ; Topiroxostat (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- 14 Apr 2021 Results presented at the Joint Meeting of the European Society of Hypertension and International Society of Hypertension
- 15 Oct 2018 New trial record